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Hyperpolarized metabolic MR in the study of cardiac function and disease
Several diseases of the heart have been linked to an insufficient ability to generate enough energy (ATP) to sustain proper
heart function. Hyperpolarized magnetic resonance (MR) is a novel technique that can visualize and quantify myocardial
energy metabolism. Hyperpolarization enhances the MR signal from a biological molecule of interest by more than 10,000
times, making it possible to measure its cellular uptake and conversion in specific enzymatic pathways in real time. We
review the role of hyperpolarized MR in identifying changes in cardiac metabolism in vivo, and present the extensive
literature on hyperpolarized pyruvate that has been used to characterize cardiac disease in various in vivo models, such
as myocardial ischemia, hypertension, diabetes, hyperthyroidism and heart failure. The technical aspects of the technique
are presented as well as the challenges of translating the technique into clinical practice. Hyperpolarized MR has the
prospect of transforming diagnostic cardiology by offering new insights into cardiac disease and potentially even to
contribute to personalized therapy based on a thorough understanding of the individual intracellular metabolism.
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